On the other hand, Jab1, acting as a modulator of intracellular signaling and affecting cellular proliferation and apoptosis and a target of STAT3 [33, 34], also decreased in FZKA-treated NSCLC cells. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.